Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-04

Clinical Trial Update: Rate of Progression in USH2A-related Retinal Degeneration

View source ↗

Summary

This clinical trial update indicates a study on the rate of progression in USH2A-related retinal degeneration is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Usher Syndrome, Type 2A, Retinitis Pigmentosa 39 | Status: ACTIVE_NOT_RECRUITING